378 related articles for article (PubMed ID: 18751909)
1. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
Fezza F; De Simone C; Amadio D; Maccarrone M
Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid amide hydrolase: a potential target for next generation therapeutics.
Maccarrone M
Curr Pharm Des; 2006; 12(6):759-72. PubMed ID: 16472164
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid amide hydrolase: from characterization to therapeutics.
Labar G; Michaux C
Chem Biodivers; 2007 Aug; 4(8):1882-902. PubMed ID: 17712824
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
Saario SM; Laitinen JT
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):287-93. PubMed ID: 17910610
[TBL] [Abstract][Full Text] [Related]
6. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
7. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
Petrosino S; Di Marzo V
Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone.
Grimaldi P; Rossi G; Catanzaro G; Maccarrone M
Vitam Horm; 2009; 81():231-61. PubMed ID: 19647115
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage.
Trabucco E; Acone G; Marenna A; Pierantoni R; Cacciola G; Chioccarelli T; Mackie K; Fasano S; Colacurci N; Meccariello R; Cobellis G; Cobellis L
Placenta; 2009 Jun; 30(6):516-22. PubMed ID: 19419760
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
11. Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.
Pillarisetti S; Alexander CW; Khanna I
Drug Discov Today; 2009 Dec; 14(23-24):1098-111. PubMed ID: 19716430
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
13. Degradation of endocannabinoids in chronic migraine and medication overuse headache.
Cupini LM; Costa C; Sarchielli P; Bari M; Battista N; Eusebi P; Calabresi P; Maccarrone M
Neurobiol Dis; 2008 May; 30(2):186-9. PubMed ID: 18358734
[TBL] [Abstract][Full Text] [Related]
14. Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes.
Battista N; Bari M; Tarditi A; Mariotti C; Bachoud-Lévi AC; Zuccato C; Finazzi-Agrò A; Genitrini S; Peschanski M; Di Donato S; Cattaneo E; Maccarrone M
Neurobiol Dis; 2007 Jul; 27(1):108-16. PubMed ID: 17553686
[TBL] [Abstract][Full Text] [Related]
15. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
Schlosburg JE; Kinsey SG; Lichtman AH
AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
[TBL] [Abstract][Full Text] [Related]
16. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids, hormone-cytokine networks and human fertility.
Maccarrone M; Falciglia K; Di Rienzo M; Finazzi-Agrò A
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):309-17. PubMed ID: 12052045
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids and their actions.
Maccarrone M; Finazzi-Agrò A
Vitam Horm; 2002; 65():225-55. PubMed ID: 12481549
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
Jonsson KO; Holt S; Fowler CJ
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids and their involvement in the neurovascular system.
Battista N; Fezza F; Maccarrone M
Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
